SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017233
Filing Date
2022-08-15
Accepted
2022-08-15 07:52:21
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inzy-20220630.htm   iXBRL 10-Q 2166054
2 EX-10.1 inzy-ex10_1.htm EX-10.1 783227
3 EX-10.2 inzy-ex10_2.htm EX-10.2 324086
4 EX-31.1 inzy-ex31_1.htm EX-31.1 21694
5 EX-31.2 inzy-ex31_2.htm EX-31.2 21864
6 EX-32.1 inzy-ex32_1.htm EX-32.1 11975
7 EX-32.2 inzy-ex32_2.htm EX-32.2 12163
  Complete submission text file 0000950170-22-017233.txt   9126803

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inzy-20220630_cal.xml EX-101.CAL 38923
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inzy-20220630.xsd EX-101.SCH 41716
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inzy-20220630_pre.xml EX-101.PRE 296038
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inzy-20220630_def.xml EX-101.DEF 154529
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inzy-20220630_lab.xml EX-101.LAB 414497
58 EXTRACTED XBRL INSTANCE DOCUMENT inzy-20220630_htm.xml XML 1503108
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39397 | Film No.: 221162388
SIC: 2834 Pharmaceutical Preparations